ReNeuron Group (RENE.L) announced the placing of 94.4 M new ordinary shares with existing and new institutional and qualifying individual shareholders on 2/22/10. This placement was comprised 2 closings and will trade on AIM.
This traunch of RENE.L’s private placement raised £4.7 M before expenses. On 3/12/10, ReNeuron announced that shareholder approval for the placement had been received and that 16.8 M shares were allotted on 1st closing and the 2nd closing on 3/19/10 with the admission of 77.6 M shares. Following the closing, the issued share capital will comprise 437,709,571 ordinary shares with NO shares are held in treasury.